GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Shiller PE Ratio

IXSBF (InNexus Biotechnology) Shiller PE Ratio : (As of Sep. 24, 2024)


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


InNexus Biotechnology Shiller PE Ratio Historical Data

The historical data trend for InNexus Biotechnology's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Shiller PE Ratio Chart

InNexus Biotechnology Annual Data
Trend Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

InNexus Biotechnology Quarterly Data
Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InNexus Biotechnology's Shiller PE Ratio

For the Biotechnology subindustry, InNexus Biotechnology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InNexus Biotechnology's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Shiller PE Ratio falls into.



InNexus Biotechnology Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

InNexus Biotechnology's E10 for the quarter that ended in Mar. 2011 is calculated as:

For example, InNexus Biotechnology's adjusted earnings per share data for the three months ended in Mar. 2011 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2011 (Change)*Current CPI (Mar. 2011)
=0/94.3376*94.3376
=0.000

Current CPI (Mar. 2011) = 94.3376.

InNexus Biotechnology Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200106 -0.009 77.983 -0.011
200109 -0.006 77.904 -0.007
200112 -0.011 76.956 -0.013
200203 -0.009 78.141 -0.011
200206 -0.027 78.931 -0.032
200209 -0.009 79.721 -0.011
200212 -0.009 79.879 -0.011
200303 -0.009 81.459 -0.010
200306 -0.008 80.985 -0.009
200309 0.007 81.459 0.008
200312 -0.020 81.538 -0.023
200403 -0.013 82.091 -0.015
200406 -0.021 83.039 -0.024
200409 -0.014 82.960 -0.016
200412 -0.021 83.276 -0.024
200503 -0.016 83.987 -0.018
200506 -0.024 84.461 -0.027
200509 -0.017 85.647 -0.019
200512 -0.024 85.015 -0.027
200603 -0.017 85.805 -0.019
200606 -0.038 86.516 -0.041
200609 -0.027 86.279 -0.030
200612 -0.035 86.437 -0.038
200703 -0.028 87.780 -0.030
200706 -0.030 88.412 -0.032
200709 -0.019 88.412 -0.020
200712 -0.050 88.491 -0.053
200803 -0.030 88.965 -0.032
200806 -0.025 91.177 -0.026
200809 -0.028 91.414 -0.029
200812 -0.024 89.518 -0.025
200903 -0.024 90.071 -0.025
200906 -0.027 90.940 -0.028
200909 -0.018 90.624 -0.019
200912 -0.019 90.703 -0.020
201003 -0.020 91.335 -0.021
201006 -0.019 91.809 -0.020
201009 -0.010 92.362 -0.010
201012 -0.010 92.836 -0.010
201103 0.000 94.338 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


InNexus Biotechnology  (GREY:IXSBF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


InNexus Biotechnology Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


InNexus Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology Headlines

No Headlines